Fresenius

FRE · Xetra · EUR

€43.64−0.38%−€0.16

Close · October 2, 2026

At a glance

Revenue growth: +4.19%; 2025 vs 2024
Net income growth: +168.37%; 2025 vs 2024
Net margin: 5.5%; 2024: 2.1%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025
Total revenue	5,945	5,818	6,156	—	5,650	5,706
Cost of revenue	4,395	4,284	4,632	—	4,189	4,292
Gross profit	1,550	1,534	1,524	—	1,461	1,414
Selling, general and administrative	760	743	824	—	741	644
Research and development	167	163	170	—	164	140
Operating income	632	601	468	—	562	689
EBIT	632	601	920	—	562	689
EBITDA	902	874	1,234	740	830	—
Pre-tax income	535	577	607	—	493	614
Income tax	136	132	180	—	147	141
Net income	382	435	361	—	330	229
Net income to common shareholders	382	435	361	—	330	229
Basic EPS	0.68	0.77	—	—	0.58	0.41
Diluted EPS	0.68	0.77	—	—	0.58	0.41
Average shares (basic)	562	563	—	—	569	563
Average shares (diluted)	562	563	—	—	569	563